Summit Therapeutics PLC Cash Flow Reinvestment Rate
Summit Therapeutics PLC cash flow reinvestment rate. Summit Therapeutics PLC (SMMT) has a Cash Flow Reinvestment Rate of 152.67x as of December 2022, reinvesting $646.06 Million (capex $994.38K plus investments $-645.06 Million) from operating cash flow of $4.23 Million. Explore Summit Therapeutics PLC debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Summit Therapeutics PLC (2004–2016)
Cash flow reinvestment rate of Summit Therapeutics PLC from 2004 to 2016. Historical reinvestment intensity for Summit Therapeutics PLC across 2 annual periods. Explore Summit Therapeutics PLC (SMMT) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Summit Therapeutics PLC Cash Flow Reinvestment Rate by Year (2004–2016)
Summit Therapeutics PLC cash flow reinvestment rate by year from 2004 to 2016. Year-by-year capital reinvestment analysis for Summit Therapeutics PLC. For the full cash flow conversion analysis, see Summit Therapeutics PLC (SMMT) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.01x | $209.99K | $15.18 Million | $110.00K | ▼ -96.9% |
| 2004 | 0.44x | $13.18K | $29.74K | $13.18K | — |